Login | Register
 Username 
 Password 
 
Login

HIV ATLAS

HIV :: TUBERCULOSIS :: MALARIA

Primary links

  • HOME
    • About Us
    • Contact Us
  • CLASSIFIED BLOGS
  • JOBS
  • EVENTS
  • LINKS
  • DAILY WIRE
  • VIDEOS
  |  
Home Blogs christin's blog

Featured Jobs

  • Dean - Indian Institute of Advanced Nursing, Chennai
  • Research Capacity Building Advisor, Haiti
  • Vacancy announcement in Afghanistan
  • Chief of Party- Kenya Public Health
  • Chief of Party/Technical Advisor, HIV-Haiti
  • DEPUTY CHIEF OF PARTY, RUSSIA
  • CHIEF OF PARTY, RUSSIA
  • Chief of Party, India
  • Chief of Party- Kenya
  • Namibia Department of Defense Program Lead

Events

  • Business leaders meet on HIV - Times LIVE
  • 11th International Workshop on Adverse Drug Reactions & Co-Morbidities in HIV Philadelphia, PA, USA, 28 October 2009 (AEGiS)
  • Aids in Culture VI: Explorations in the Cultural History of AIDS International Conference. Mexico City, 9 - 14 December 2010
  • Sexual Health Conference in Bali, May 4-6
  • CBCP calls for summit on HIV-AIDS - ABS CBN News
  • ASEAN youth meet to map out HIV/AIDS prevention activities - Xinhua
  • Gujarat - Get togehter 3000 PLHAs at Capital of Gujarat
  • International Symposium on HIV & Emerging Infectious Diseases.
  • India NGO Awards 2009
  • HIV Congress 2010

HIV-1-specific CD8+ T cell responses during primary infection are major determinants of the viral set ...

Submitted by christin on Sat, 05/23/2009 - 18:02
  • Abstracts and Research
  • World Wide

HIV-1-specific CD8+ T cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. - Related Articles
HIV-1-specific CD8+ T cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells.
J Virol. 2009 May 20;
Authors: Streeck H, Jolin JS, Qi Y, Yassine-Diab B, Johnson RC, Kwon DS, Addo MM, Brumme C, Routy JP, Little S, Jessen HK, Kelleher AD, Hecht FM, Sekaly RP, Rosenberg ES, Walker BD, Carrington M, Altfeld M
Primary HIV-1 infection (PHI) is marked by a flu-like syndrome and high levels of viremia that decrease to a viral set point with the first emergence of virus-specific CD8+ T cell responses. Here we investigated in a large cohort of 527 subjects the immunodominance pattern of the first virus-specific CTL responses developed during PHI in comparison to CTL responses in chronic infection, and demonstrate a distinct relationship between the early virus-specific CTL responses and viral set point as well as the slope of CD4+ decline. CTL responses during PHI followed clear hierarchical immunodominance patterns that were lost during the transition to chronic infection. Importantly, the immunodominance patterns of HIV-1-specific CTL responses detected in primary, but not in chronic HIV-1 infection, were significantly associated with the subsequent set point of viral replication. Moreover, the preservation of the initial CD8+ T cell immunodominance patterns from the acute into the chronic phase of infection was significantly associated with slower CD4+ T cell decline. Taken together, these data show that the specificity of the initial CTL response to HIV is critical for the subsequent control of viremia, and have important implications for the rational selection of antigens for future HIV-1 vaccines.
PMID: 19458000 [PubMed - as supplied by publisher]
[PubMed-HIV]

  • christin's blog
  • Login or register to post comments
  • Printer-friendly version

RESOURCES

  • AEGiS
  • AIDS.gov
  • AIDS_ASIA
  • AIDS-INDIA
  • AIDSPORTAL.org
  • About.com
  • Aids-write.org
  • All Africa.com
  • CDC
  • Children & HIV
  • Clinical Care Options HIV
  • DailyMed
  • EATG
  • EBLING LIBRARY
  • Eldis-Jobs
  • Eldis.org
  • GNP Latest news
  • Google-Homophobia
  • Google-HIV Baby-sitting
  • Google HIV NEWS
  • Google MALARIA NEWS
  • Google TB NEWS
  • HIV Law Project
  • HIV Positive Dating
  • HIV Twinning News
  • Hivdatfla
  • Hivsnp
  • IAVI
  • IFANET-INDIA
  • IGIB/CSIR
  • DevNetJobs
  • Indeed.com
  • Iran HIV AIDS
  • Juju-HIV
  • Kaiser-Child health
  • Kaiser HIV/AIDS
  • Kaiser Malaria
  • Kaiser-Tuberculosis
  • Kaiser-U.S. HIV
  • Medical News-HIV
  • Medical News-TB
  • MEDSCAPE
  • Medsin Manchester
  • National AIDS Map
  • Nature Jobs
  • Nets at Harvard University
  • NIAID
  • NMAC
  • NIH.gov
  • NMPrev
  • OpenSource.org.in
  • Oxfam Jobs
  • Partners Zambia
  • Policy and Ethics
  • PozHealth
  • PubMed-HIV
  • PubMed-Malaria
  • RBM Topline Stories
  • SAATHII
  • Save The Children
  • Treatment Action Campaign
  • Tuberculous-Meningitis
  • Tuberculosis-Pulmonary
  • UKLug-HIV
  • UKLug-Tuberculosis
  • UNAIDS-JOBS
  • UNAIDS-SERVICE
  • UNICEF News
  • UNICEF Photo Essays
  • WHO
  • Women & HIV
Every 9½ minutes someone in the US is infected with HIV. Act Against AIDS. Get the facts: NineAndaHalfMinutes.org

ABOUT HIV ATLAS

A Social Media initiative that aims to Collect, Collate, Classify and Disseminate the information on HIV, TB & Malaria so that people living with HIV and the people working in the field can be on top of the information generating from more than 700 online and offline resources.

HIV ATLAS provides its users a unique way to be on top of information ranging from common living to funding, jobs, events and much more absolutely free of charge. We encourage Employers to post their Job opportunities in our featured Jobs cateogry to reach out to more than 40000 subscribers daily.

JOIN HIV ATLAS

HIV ATLAS welcomes content contributions and strongly encourages all sector participants to actively share their advertisements.

You can contribute and engage by:
- Creating your profile
- Posting your classified advertisements
- sharing information about Jobs, Events, Funding etc with us
- sharing information about any online resource you want us to include
- creating your resume for potential employers to have a look in.

NEWLETTER SUBSCRIPTIONS

Manage your newsletter subscriptions
Select the newsletter(s) to which you want to subscribe or unsubscribe.
  Copyright © 2004-2009 HIV ATLAS.org. All rights reserved. | Legal | Contact Powered by Halosys Technologies Inc.  

Disclaimer: This site contains HIV prevention messages that may not be appropriate for all audiences.